Weill Cornell Funded for Metabolomics Research into Tuberculosis
January 11, 2013
Weill Cornell Funded for Metabolomics Research into Tuberculosis
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- With Exclusive License to Marker, Empire to Launch Neuroendocrine Prostate Cancer Dx This Year
May 22, 2013 / Pharmacogenomics Reporter - NIDDK to Fund Biomarker, Assay Projects Using Samples and Data from Its Repository
May 17, 2013 / GenomeWeb Daily News - UW Researchers Commercializing Nanotip Device for DNA Isolation; Exploring Tech for POC Dx
May 16, 2013 / PCR Insider - Agilent Restructures, Laying off 450; Q2 Revenues Flat
May 15, 2013 / GenomeWeb Daily News - China's Zeesan Biotech Developing Portfolio of Melt Curve MDx Assays after SFDA Approves TB Tests
April 25, 2013 / PCR Insider